Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
42 hedge funds and large institutions have $42.5M invested in Chembio diagnostics, Inc. in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 6
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
24% more funds holding
Funds holding: 34 → 42 (+8)
41% less capital invested
Capital invested by funds: $71.8M → $42.5M (-$29.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$6.04M |
| 2 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$2.57M |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.77M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$1.58M |
| 5 |
RA
Royce & Associates
New York
|
+$1.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$12.1M |
| 2 |
AIP
ARS Investment Partners
New York
|
-$1.66M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$860K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$772K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$305K |
CEMI Hedge Fund Activity: Q4 2018 in Review
42 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q4 2018, worth a combined $42.5M — down 41% from $71.8M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CEMI positions and 6 closed out — a net gain of 8 holders — while 18 added to existing stakes and 6 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $6.04M. The largest seller was Acuta Capital Partners, cutting an estimated $12.1M.
- 42 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q4 2018, up from 34 in Q3 2018.
- Funds reported $42.5M of Chembio diagnostics, Inc. stock for Q4 2018, down 41% quarter-over-quarter.
- 14 funds opened new Chembio diagnostics, Inc. positions in Q4 2018 and 6 closed out, a net change of +8 holders.
- The largest Chembio diagnostics, Inc. buyer in Q4 2018 was Nantahala Capital Management, an estimated $6.04M added.
- The largest Chembio diagnostics, Inc. seller in Q4 2018 was Acuta Capital Partners, an estimated $12.1M sold.
Based on aggregated 13F filings for Q4 2018.